We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

rhEndostatin Protein Involving Pediatric Patients With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00165373
Recruitment Status : Terminated (Lack of drug supply)
First Posted : September 14, 2005
Last Update Posted : December 28, 2007
Boston Children’s Hospital
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2005
  Study Completion Date : January 2005